The effect of non-alcoholic fatty liver disease on virologic response in patients with hepatitis B e

来源 :China Medical Abstracts(Internal Medicine) | 被引量 : 0次 | 上传用户:luoqiaoshui
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Objective To investigate the effect of non-alcoholic fatty liver disease(NAFLD)on virologic response in chronic hepatitis B patients treated with nucleoside analogues.Methods Three hundred and thirty-two treatment-naive patients with hepatitis B e antigen(HBeAg)-positive chronic hepatitis B(CHB)who visited clinic or hospitalized in the First Affiliated Hospital of Wenzhou Medical College from January 2007 to December 2009 Objective To investigate the effect of non-alcoholic fatty liver disease (NAFLD) on virologic response in chronic hepatitis B patients treated with nucleoside analogues. Methods Three hundred and thirty-two treatment-naive patients with hepatitis B e antigen (HBeAg) -positive chronic hepatitis B (CHB) who visited clinic or hospitalized in the First Affiliated Hospital of Wenzhou Medical College from January 2007 to December 2009
其他文献
[目的]探讨腹腔镜手术在治疗盆腔手术后休克型输卵管妊娠中的优越性。[方法]54例盆腔手术史,休克型输卵管妊娠患者随机分为腹腔镜手术组(研究组24例)和开腹手术组(对照组30例
从知识管理情境的角度,文章描述了在知识转移过程中由于知识的边界性而引发的对知识认知偏差的现象;对密切影响图书馆知识转移情境因素和认知判断偏差进行研究,说明情境因素
统筹城乡发展对城乡公共图书馆传统发展模式提出了挑战,也提供了难得的机遇。针对二元结构体制下城乡公共图书馆存在的问题,提出了这一重要转型时期城乡公共图书馆如何把握城
AIM:To investigate the safety and efficacy of a Hansenula-derived PEGylated(polyethylene glycol)interferon(IFN)-alpha-2a(Reiferon Retard)plus ribavirin customiz
Objective:To investigate what kind of mosquito sample is necessary for the determination of insecticide susceptibility in malaria vectors.Methods:Larvae and pup
本刊讯随着黄河流域进入春灌用水高峰期,刘家峡水电厂日前开始加大出库流量,向下游补水,以确保宁夏、内蒙古等地的春季农田灌溉。从4月中旬开始,刘家峡水电厂将日均出库流量
利用耗散结构理论对图书馆信息资源系统结构进行分析讨论,并应用申农信息熵模型计算图书馆信息资源系统的熵值。在巨涨落作用下,图书馆信息资源系统内产生耗散结构,使信息资
Objective To investigate the clinical curative effect and outcomes of multidrug-resistant tuberculosis(MDRTB)in elderly patients.Methods Fifty-nine elderly pati
The ideal endpoint of hepatitis B virus(HBV)antiviral therapy is HBsAg loss,a difficult goal to obtain,especially in HBeAg negative patients.Herein,we report th
Hepatitis B virus(HBV)is the leading cause of liver disease and infects an estimated 240 million people worldwide.It is characterised by a high degree of geneti